Genome-Wide Mutagenesis Reveals That ORF7 Is a Novel VZV Skin-Tropic Factor

English version České info

The Varicella Zoster Virus (VZV) is a ubiquitous human alpha-herpesvirus that is the causative agent of chicken pox and shingles. Although an attenuated VZV vaccine (v-Oka) has been widely used in children in the United States, chicken pox outbreaks are still seen, and the shingles vaccine only reduces the risk of shingles by 50%. Therefore, VZV still remains an important public health concern. Knowledge of VZV replication and pathogenesis remains limited due to its highly cell-associated nature in cultured cells, the difficulty of generating recombinant viruses, and VZV's almost exclusive tropism for human cells and tissues. In order to circumvent these hurdles, we cloned the entire VZV (p-Oka) genome into a bacterial artificial chromosome that included a dual-reporter system (GFP and luciferase reporter genes). We used PCR-based mutagenesis and the homologous recombination system in the E. coli to individually delete each of the genome's 70 unique ORFs. The collection of viral mutants obtained was systematically examined both in MeWo cells and in cultured human fetal skin organ samples. We use our genome-wide deletion library to provide novel functional annotations to 51% of the VZV proteome. We found 44 out of 70 VZV ORFs to be essential for viral replication. Among the 26 non-essential ORF deletion mutants, eight have discernable growth defects in MeWo. Interestingly, four ORFs were found to be required for viral replication in skin organ cultures, but not in MeWo cells, suggesting their potential roles as skin tropism factors. One of the genes (ORF7) has never been described as a skin tropic factor. The global profiling of the VZV genome gives further insights into the replication and pathogenesis of this virus, which can lead to improved prevention and therapy of chicken pox and shingles.

Vyšlo v časopise: Genome-Wide Mutagenesis Reveals That ORF7 Is a Novel VZV Skin-Tropic Factor. PLoS Pathog 6(7): e32767. doi:10.1371/journal.ppat.1000971
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1000971

Souhrn

Zdroje

1. AbendrothA

ArvinA

1999 Varicella-zoster virus immune evasion. Immunol Rev 168 143 156

2. CohenJI

StrausSE

ArvinAM

2007 Varicella-Zoster Virus Replication, Pathogenesis, and Management.

KnipeDM

HowleyPM

Fields Virology. 5th ed Philadelphia, PA Lippincott Williams & Wilkins 2773 2818

3. GildenDH

Kleinschmidt-DeMastersBK

LaGuardiaJJ

MahalingamR

CohrsRJ

2000 Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 342 635 645

4. Centers for Disease Control and Prevention 2003 Decline in annual incidence of varicella—selected states, 1990–2001. MMWR Morb Mortal Wkly Rep 52 884 885

5. GershonAA

ArvinAM

ShapiroE

2007 Varicella vaccine. New England Journal of Medicine 356 2648 2649

6. LopezAS

KolasaMS

SewardJF

2008 Status of school entry requirements for varicella vaccination and vaccination coverage 11 years after implementation of the varicella vaccination program. J Infect Dis 197 Suppl 2 S76 81

7. MarinM

MeissnerHC

SewardJF

2008 Varicella prevention in the United States: a review of successes and challenges. Pediatrics 122 e744 751

8. SewardJF

WatsonBM

PetersonCL

MascolaL

PelosoJW

2002 Varicella disease after introduction of varicella vaccine in the United States, 1995–2000. Jama-Journal of the American Medical Association 287 606 611

9. VazquezM

LaRussaPS

GershonAA

NiccolaiLM

MuehlenbeinCE

2004 Effectiveness over time of varicella vaccine. Jama-Journal of the American Medical Association 291 851 855

10. VazquezM

LaRussaPS

GershonAA

SteinbergSP

FreudigmanK

2001 The effectiveness of the varicella vaccine in clinical practice. New England Journal of Medicine 344 955 960

11. GalilK

LeeB

StrineT

CarraherC

BaughmanAL

2002 Outbreak of varicella at a day-care center despite vaccination. New England Journal of Medicine 347 1909 1915

12. GershonAA

SteinbergSP

GelbL

GalassoG

BorkowskyW

1984 Live Attenuated Varicella Vaccine - Efficacy for Children with Leukemia in Remission. Jama-Journal of the American Medical Association 252 355 362

13. IzurietaHS

StrebelPM

BlakePA

1997 Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center. Jama-Journal of the American Medical Association 278 1495 1499

14. OxmanMN

LevinMJ

JohnsonGR

SchmaderKE

StrausSE

2005 A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. New England Journal of Medicine 352 2271 2284

15. ArvinAM

2001 Varicella-Zoster Virus.

KnipeDM

HowleyPM

Fields Virology Philadelphia, PA Lippincott Williams & Wilkins 2731 2767

16. NiizumaT

ZerboniL

SommerMH

ItoH

HinchliffeS

2003 Construction of varicella-zoster virus recombinants from parent Oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID-hu mouse model. J Virol 77 6062 6065

17. CohenJI

SeidelKE

1993 Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro. Proc Natl Acad Sci U S A 90 7376 7380

18. MoffatJF

SteinMD

KaneshimaH

ArvinAM

1995 Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice. J Virol 69 5236 5242

19. ZhangZ

RoweJ

WangW

SommerM

ArvinA

2007 Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system. J Virol 81 9024 9033

20. TaylorSL

MoffatJF

2005 Replication of varicella-zoster virus in human skin organ culture. J Virol 79 11501 11506

21. ArvinAM

2006 Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model. Herpes 13 75 80

22. ZhangZ

HuangY

ZhuH

2008 A highly efficient protocol of generating and analyzing VZV ORF deletion mutants based on a newly developed luciferase VZV BAC system. J Virol Methods 148 197 204

23. DefechereuxP

MelenL

BaudouxL

Merville-LouisMP

RentierB

1993 Characterization of the regulatory functions of varicella-zoster virus open reading frame 4 gene product. J Virol 67 4379 4385

24. MoriuchiH

MoriuchiM

SmithHA

CohenJI

1994 Varicella-zoster virus open reading frame 4 protein is functionally distinct from and does not complement its herpes simplex virus type 1 homolog, ICP27. J Virol 68 1987 1992

25. MoriuchiH

MoriuchiM

StrausSE

CohenJI

1993 Varicella-zoster virus (VZV) open reading frame 61 protein transactivates VZV gene promoters and enhances the infectivity of VZV DNA. J Virol 67 4290 4295

26. PereraLP

MoscaJD

Sadeghi-ZadehM

RuyechanWT

HayJ

1992 The varicella-zoster virus immediate early protein, IE62, can positively regulate its cognate promoter. Virology 191 346 354

27. SatoB

ItoH

HinchliffeS

SommerMH

ZerboniL

2003 Mutational analysis of open reading frames 62 and 71, encoding the varicella-zoster virus immediate-early transactivating protein, IE62, and effects on replication in vitro and in skin xenografts in the SCID-hu mouse in vivo. J Virol 77 5607 5620

28. SatoB

SommerM

ItoH

ArvinAM

2003 Requirement of varicella-zoster virus immediate-early 4 protein for viral replication. J Virol 77 12369 12372

29. CohenJI

CoxE

PesnicakL

SrinivasS

KrogmannT

2004 The varicella-zoster virus open reading frame 63 latency-associated protein is critical for establishment of latency. J Virol 78 11833 11840

30. BaikerA

BagowskiC

ItoH

SommerM

ZerboniL

2004 The immediate-early 63 protein of Varicella-Zoster virus: analysis of functional domains required for replication in vitro and for T-cell and skin tropism in the SCIDhu model in vivo. J Virol 78 1181 1194

31. SommerMH

ZaghaE

SerranoOK

KuCC

ZerboniL

2001 Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus. J Virol 75 8224 8239

32. MoC

SuenJ

SommerM

ArvinA

1999 Characterization of Varicella-Zoster virus glycoprotein K (open reading frame 5) and its role in virus growth. J Virol 73 4197 4207

33. YamagishiY

SadaokaT

YoshiiH

SomboonthumP

ImazawaT

2008 Varicella-zoster virus glycoprotein M homolog is glycosylated, is expressed on the viral envelope, and functions in virus cell-to-cell spread. J Virol 82 795 804

34. DuusKM

GroseC

1996 Multiple regulatory effects of varicella-zoster virus (VZV) gL on trafficking patterns and fusogenic properties of VZV gH. J Virol 70 8961 8971

35. MaresovaL

KutinovaL

LudvikovaV

ZakR

MaresM

2000 Characterization of interaction of gH and gL glycoproteins of varicella-zoster virus: their processing and trafficking. Journal of General Virology 81 1545 1552

36. MalloryS

SommerM

ArvinAM

1998 Analysis of the glycoproteins I and E of varicella-zoster virus (VZV) using deletional mutations of VZV cosmids. Journal of Infectious Diseases 178 S22 S26

37. GharaviS

SadeghizadehM

HosseinkhaniS

SabahiF

2007 A study of varicella zoster virus glycoprotein C regulatory region response to viral activators in vitro. Pak J Biol Sci 10 2140 2145

38. MoffatJF

ZerboniL

KinchingtonPR

GroseC

KaneshimaH

1998 Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J Virol 72 965 974

39. MalloryS

SommerM

ArvinAM

1997 Mutational analysis of the role of glycoprotein I in Varicella-Zoster virus replication and its effects on glycoprotein E conformation and tracking. Journal of Virology 71 8279 8288

40. MoffatJ

ItoH

SommerM

TaylorS

ArvinAM

2002 Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells. J Virol 76 8468 8471

41. StallingsCL

SilversteinS

2005 Dissection of a novel nuclear localization signal in open reading frame 29 of varicella-zoster virus. J Virol 79 13070 13081

42. RobertsCR

WeirAC

HayJ

StrausSE

RuyechanWT

1985 DNA-binding proteins present in varicella-zoster virus-infected cells. J Virol 55 45 53

43. ChaudhuriV

SommerM

RajamaniJ

ZerboniL

ArvinAM

2008 Functions of Varicella-zoster virus ORF23 capsid protein in viral replication and the pathogenesis of skin infection. J Virol 82 10231 10246

44. ItoH

SommerMH

ZerboniL

BaikerA

SatoB

2005 Role of the varicella-zoster virus gene product encoded by open reading frame 35 in viral replication in vitro and in differentiated human skin and T cells in vivo. J Virol 79 4819 4827

45. HeinemanTC

CohenJI

1994 Deletion of the varicella-zoster virus large subunit of ribonucleotide reductase impairs growth of virus in vitro. J Virol 68 3317 3323

46. ReddySM

CoxE

IofinI

SoongW

CohenJI

1998 Varicella-zoster virus (VZV) ORF32 encodes a phosphoprotein that is posttranslationally modified by the VZV ORF47 protein kinase. J Virol 72 8083 8088

47. CohenJI

SeidelK

1994 Varicella-zoster virus (VZV) open reading frame 10 protein, the homolog of the essential herpes simplex virus protein VP16, is dispensable for VZV replication in vitro. J Virol 68 7850 7858

48. HeinemanTC

CohenJI

1995 The varicella-zoster virus (VZV) open reading frame 47 (ORF47) protein kinase is dispensable for viral replication and is not required for phosphorylation of ORF63 protein, the VZV homolog of herpes simplex virus ICP22. J Virol 69 7367 7370

49. SatoH

PesnicakL

CohenJI

2002 Varicella-zoster virus open reading frame 2 encodes a membrane phosphoprotein that is dispensable for viral replication and for establishment of latency. J Virol 76 3575 3578

50. CohenJI

SeidelKE

1995 Varicella-zoster virus open reading frame 1 encodes a membrane protein that is dispensable for growth of VZV in vitro. Virology 206 835 842

51. CohenJI

SeidelKE

1994 Absence of varicella-zoster virus (VZV) glycoprotein V does not alter growth of VZV in vitro or sensitivity to heparin. J Gen Virol 75(Pt 11) 3087 3093

52. CoxE

ReddyS

IofinI

CohenJI

1998 Varicella-zoster virus ORF57, unlike its pseudorabies virus UL3.5 homolog, is dispensable for viral replication in cell culture. Virology 250 205 209

53. YoshiiH

SadaokaK

MatsuuraM

NagaikeK

TakahashiM

2008 Varicella-zoster virus ORF 58 gene is dispensable for viral replication in cell culture. Virol J 5 54

54. CohenJI

SatoH

SrinivasS

LekstromK

2001 Varicella-zoster virus (VZV) ORF65 virion protein is dispensable for replication in cell culture and is phosphorylated by casein kinase II, but not by the VZV protein kinases. Virology 280 62 71

55. CheX

ZerboniL

SommerMH

ArvinAM

2006 Varicella-zoster virus open reading frame 10 is a virulence determinant in skin cells but not in T cells in vivo. J Virol 80 3238 3248

56. CheXB

BerarducciB

SommerM

RuyechanWT

ArvinAM

2007 The ubiquitous cellular transcriptional factor USF targets the varicella-zoster virus open reading frame 10 promoter and determines virulence in human skin xenografts in SCIDhu mice in vivo. Journal of Virology 81 3229 3239

57. KluppBG

GranzowH

KlopfleischR

FuchsW

KoppM

2005 Functional analysis of the pseudorabies virus UL51 protein. Journal of Virology 79 3831 3840

58. RoizmanB

KnipeDM

WhitleyRJ

2007 Herpes simplex viruses.

KnipeDM

HowleyPM

Fields Virology. 5th ed Philadelphia, PA Lippincott Williams & Wilkins 2399 2460

59. DunnW

ChouC

LiH

HaiR

PattersonD

2003 Functional profiling of a human cytomegalovirus genome. Proc Natl Acad Sci U S A 100 14223 14228

60. RossJ

WilliamsM

CohenJI

1997 Disruption of the varicella-zoster virus dUTPase and the adjacent ORF9A gene results in impaired growth and reduced syncytia formation in vitro. Virology 234 186 195

61. DeslogesN

RahausM

WolffMH

2005 The varicella-zoster virus-mediated delayed host shutoff: open reading frame 17 has no major function, whereas immediate-early 63 protein represses heterologous gene expression. Microbes and Infection 7 1519 1529

62. SatoH

CallananLD

PesnicakL

KrogmannT

CohenJI

2002 Varicella-zoster virus (VZV) ORF17 protein induces RNA cleavage and is critical for replication of VZV at 37 degrees C but not 33 degrees C. Journal of Virology 76 11012 11023

63. CohenJI

NguyenH

1998 Varicella-zoster virus ORF61 deletion mutants replicate in cell culture, but a mutant with stop codons in ORF61 reverts to wild-type virus. Virology 246 306 316

64. WangL

SommerM

RajamaniJ

ArvinAM

2009 Regulation of the ORF61 Promoter and ORF61 Functions in Varicella-Zoster Virus Replication and Pathogenesis. Journal of Virology 83 7560 7572

65. HeinemanTC

SeidelK

CohenJI

1996 The varicella-zoster virus ORF66 protein induces kinase activity and is dispensable for viral replication. Journal of Virology 70 7312 7317

66. KinchingtonPR

FiteK

SemanA

TurseSE

2001 Virion association of IE62, the varicella-zoster virus (VZV) major transcriptional regulatory protein, requires expression of the VZV open reading frame 66 protein kinase. Journal of Virology 75 9106 9113

67. ErazoA

YeeMB

OsterriederN

KinchingtonPR

2008 Varicella-zoster virus open reading frame 66 protein kinase is required for efficient viral growth in primary human corneal stromal fibroblast cells. Journal of Virology 82 7653 7665

68. SchaapA

FortinJF

SommerM

ZerboniL

StamatisS

2005 T-Cell tropism and the role of ORF66 protein in pathogenesis of varicella-zoster virus infection. Journal of Virology 79 12921 12933

69. MarchiniA

LiuH

ZhuH

2001 Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J Virol 75 1870 1878

70. GentlemanRC

CareyVJ